Follow the CLOROX CO stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Food & Agriculture sector, CLOROX CO has published 272 insider filings. Market capitalisation: €11.3bn. The latest transaction was filed on 24 July 2026 (Retenue fiscale). Among the most active insiders: Grier Stacey. The full history is free.
Analysts rate CLOROX CO Hold (neutral), based on 17 analysts. Average price target: US$104.65.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 272 declarations
The Clorox Company (NYSE: CLX) is a leading U.S. consumer products group with a strong position in household care, disinfecting, hygiene, and selected food-related categories. Founded in 1913 as The Electro-Alkaline Company, Clorox started with liquid bleach production in Oakland, California, where the company is still headquartered today. Over more than a century, it has evolved from a single-product bleach business into a diversified branded platform sold in more than 100 markets, with operations in approximately 25 countries or territories. For French-speaking investors in Europe, Clorox is best viewed as a defensive U.S. listed consumer staples company, traded on the NYSE in the United States, with revenues supported by essential everyday products and strong brand loyalty. Clorox’s portfolio spans several core business lines. Its health and wellness activities include cleaning and disinfecting products, laundry additives, and professional offerings. Its lifestyle segment covers dressings, dips, seasonings, sauces, water-filtration products, and natural personal care. Well-known brands include Clorox, Pine-Sol, Tilex, Liquid-Plumr, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, and Burt’s Bees. The company also serves professional customers through CloroxPro and Clorox Healthcare. This broad portfolio gives Clorox exposure to both at-home consumption and institutional use cases, while reducing reliance on any single brand or subcategory. From a competitive standpoint, Clorox competes against large national brands as well as private-label products. Its edge comes from brand equity, distribution reach, category expertise, and ongoing product innovation. The company says about 80% of sales come from brands that hold a No. 1 or No. 2 market share position in their categories, which is an important indicator of franchise strength. Clorox primarily focuses on midsized categories that it considers financially attractive, rather than chasing broad commodity exposure. That strategy supports pricing power and margin resilience, although execution remains sensitive to supply chain conditions, input costs, retailer inventory patterns, and marketing effectiveness. Recent developments are important for investors. In April 2026, Clorox completed the acquisition of GOJO Industries, maker of Purell, expanding its portfolio into hand hygiene and health solutions. Management described the deal as complementary to Clorox’s consumer brand-building capabilities and its B2B strengths. In its latest quarterly updates for fiscal 2026, the company noted that results were influenced by ERP-related inventory dynamics in the United States, while also pointing to the contribution expected from GOJO. Clorox therefore remains a mature but evolving consumer staples name: a household-product leader with international reach, a long operating history, a strong U.S. NYSE listing, and a portfolio that is being adjusted to capture additional health and hygiene demand.